Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2515-8
Published Online: 2014-06-20
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Keun-Wook
Kim, Yu Jung
Lee, Kyung-Hun
Han, Sae-Won
Kim, Tae-Yong
Oh, Do-Youn
Im, Seock-Ah
Kim, Tae-You
Bang, Yung-Jue
Choi, In Sil
Kim, Jee Hyun
Text and Data Mining valid from 2014-06-20